Rollins Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$539K Sell
3,441
-711
-17% -$109K 0.11% 64
2023
Q3
$647K Sell
4,152
-895
-18% -$148K 0.16% 62
2023
Q2
$835K Buy
5,047
+2,407
+91% +$388K 0.23% 50
2023
Q1
$409K Sell
2,640
-112
-4% -$18.1K 0.14% 73
2022
Q4
$486K Buy
2,752
+115
+4% +$19.9K 0.18% 72
2022
Q3
$431K Sell
2,637
-1,112
-30% -$188K 0.16% 57
2022
Q2
$666K Sell
3,749
-885
-19% -$158K 0.23% 48
2022
Q1
$821K Buy
4,634
+2
+0% +$340 0.24% 46
2021
Q4
$792K Buy
+4,632
New +$758K 0.23% 44
2021
Q2
$750K Buy
4,552
+1,345
+42% +$223K 0.27% 43
2021
Q1
$527K Buy
3,207
+313
+11% +$50.6K 0.23% 57
2020
Q4
$455K Buy
+2,894
New +$427K 0.21% 50

Other funds holding JNJ

Rollins Financial's JNJ Position: Q4 2023 in Review

Rollins Financial reduced its Johnson & Johnson (JNJ) stake by 17% in Q4 2023, selling an estimated $109K and leaving 3,441 shares worth $539K. The position accounts for 0.11% of the portfolio, ranked #64.

Rollins Financial first reported a position in JNJ in Q4 2020 and has held it in 12 quarters since. The position peaked at $835K in Q2 2023. 3,875 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Rollins Financial held 3,441 shares of Johnson & Johnson worth $539K as of Q4 2023.
  • Rollins Financial sold 711 Johnson & Johnson shares in Q4 2023, an estimated $109K.
  • Johnson & Johnson made up 0.11% of Rollins Financial's portfolio in Q4 2023, its #64 holding.
  • Rollins Financial first reported a position in Johnson & Johnson in Q4 2020 and has held it in 12 quarters since.
  • Rollins Financial's Johnson & Johnson position peaked at $835K in Q2 2023.
  • 3,875 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Rollins Financial's 13F filing for Q4 2023, filed 6 Feb 2024.